MMAMaltese National Competent Authority. http://medicinesauthority.gov.mt/"
Market exclusivityThe 10-year period after the marketing authorisation of an orphan medicine, during which similar medicines for the same indication cannot be placed on the market. Market exclusivity should not be confused with market protection or data exclusivity, market exclusivity refers only to orphan(...)
Marketing AuthorisationMarketing authorisation (MA) refers to the approval for a medicine to be marketed.A system of marketing authorisation was put in place to protect public health. Marketing authorisations are granted only when a competent authority (or ‘regulatory authority’) has conducted a scientific(...)
MAMarketing authorisation (MA) refers to the approval for a medicine to be marketed.A system of marketing authorisation was put in place to protect public health. Marketing authorisations are granted only when a competent authority (or ‘regulatory authority’) has conducted a scientific(...)
Marketing Authorisation HolderA Marketing Authorisation Holder (MAH) is a company, firm or non-profit organisation that has been granted a marketing authorisation. The marketing authorisation allows the holder to market a specific medicinal product, in one or more EU member states. Once a medicinal product is marketed and(...)
MAHA Marketing Authorisation Holder (MAH) is a company, firm or non-profit organisation that has been granted a marketing authorisation. The marketing authorisation allows the holder to market a specific medicinal product, in one or more EU member states. Once a medicinal product is marketed and(...)
Maximum Tolerated DoseThe maximum tolerated dose (MTD) is the highest dose of a medicine or treatment that will produce the desired effect without resulting in unacceptable side effects. It is determined in clinical trials by testing increasing doses on different groups of people until the highest dose with(...)
